CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC=Breast

Cancers, Free Full-Text

Impact of HER2-low status for patients with early-stage breast

Cancers, Free Full-Text

The impact of erythropoiesis-stimulating agents administration

National Surgical Adjuvant Breast and Bowel Project (NSABP)

Gemcitabine as adjuvant chemotherapy in patients with high-risk

HER2-enriched subtype and novel molecular subgroups drive

Consort diagram. Anthracyclines in early breast cancer (ABC

The impact of erythropoiesis-stimulating agents administration

Mixed invasive ductal lobular carcinoma is clinically and

PIK3CA alterations and benefit with neratinib: analysis from the

Alterations in immune cell phenotype and cytotoxic capacity in

A population-based study on the patterns of use of different

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel

Immunological and clinicopathological features predict HER2